These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

362 related items for PubMed ID: 16020742

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Phosphorylation of PPARs: from molecular characterization to physiological relevance.
    Diradourian C, Girard J, Pégorier JP.
    Biochimie; 2005 Jan; 87(1):33-8. PubMed ID: 15733734
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Targeting components of the stress system as potential therapies for the metabolic syndrome: the peroxisome-proliferator-activated receptors.
    Yumuk VD.
    Ann N Y Acad Sci; 2006 Nov; 1083():306-18. PubMed ID: 17148746
    [Abstract] [Full Text] [Related]

  • 7. Conformational rearrangements and signaling cascades involved in ligand-biased mitogen-activated protein kinase signaling through the beta1-adrenergic receptor.
    Galandrin S, Oligny-Longpré G, Bonin H, Ogawa K, Galés C, Bouvier M.
    Mol Pharmacol; 2008 Jul; 74(1):162-72. PubMed ID: 18403719
    [Abstract] [Full Text] [Related]

  • 8. Peroxisome proliferator-activated receptors (PPARs) in the control of bone metabolism.
    Giaginis C, Tsantili-Kakoulidou A, Theocharis S.
    Fundam Clin Pharmacol; 2007 Jun; 21(3):231-44. PubMed ID: 17521292
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Peroxisome proliferator-activated receptors and inflammation.
    Moraes LA, Piqueras L, Bishop-Bailey D.
    Pharmacol Ther; 2006 Jun; 110(3):371-85. PubMed ID: 16168490
    [Abstract] [Full Text] [Related]

  • 11. Cross-talk between vitamin D receptor (VDR)- and peroxisome proliferator-activated receptor (PPAR)-signaling in melanoma cells.
    Sertznig P, Dunlop T, Seifert M, Tilgen W, Reichrath J.
    Anticancer Res; 2009 Sep; 29(9):3647-58. PubMed ID: 19667161
    [Abstract] [Full Text] [Related]

  • 12. Peroxisome proliferator-activated receptors and inflammation: take it to heart.
    Smeets PJ, Planavila A, van der Vusse GJ, van Bilsen M.
    Acta Physiol (Oxf); 2007 Nov; 191(3):171-88. PubMed ID: 17935522
    [Abstract] [Full Text] [Related]

  • 13. Peroxisome proliferator-activated receptors as transcriptional nodal points and therapeutic targets.
    Brown JD, Plutzky J.
    Circulation; 2007 Jan 30; 115(4):518-33. PubMed ID: 17261671
    [Abstract] [Full Text] [Related]

  • 14. International Union of Pharmacology. LXI. Peroxisome proliferator-activated receptors.
    Michalik L, Auwerx J, Berger JP, Chatterjee VK, Glass CK, Gonzalez FJ, Grimaldi PA, Kadowaki T, Lazar MA, O'Rahilly S, Palmer CN, Plutzky J, Reddy JK, Spiegelman BM, Staels B, Wahli W.
    Pharmacol Rev; 2006 Dec 30; 58(4):726-41. PubMed ID: 17132851
    [Abstract] [Full Text] [Related]

  • 15. Adiponectin increases fatty acid oxidation in skeletal muscle cells by sequential activation of AMP-activated protein kinase, p38 mitogen-activated protein kinase, and peroxisome proliferator-activated receptor alpha.
    Yoon MJ, Lee GY, Chung JJ, Ahn YH, Hong SH, Kim JB.
    Diabetes; 2006 Sep 30; 55(9):2562-70. PubMed ID: 16936205
    [Abstract] [Full Text] [Related]

  • 16. Dependence of peroxisome proliferator-activated receptor ligand-induced mitogen-activated protein kinase signaling on epidermal growth factor receptor transactivation.
    Gardner OS, Dewar BJ, Earp HS, Samet JM, Graves LM.
    J Biol Chem; 2003 Nov 21; 278(47):46261-9. PubMed ID: 12966092
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Obesity, peroxisome proliferator-activated receptor, and atherosclerosis in type 2 diabetes.
    Blaschke F, Takata Y, Caglayan E, Law RE, Hsueh WA.
    Arterioscler Thromb Vasc Biol; 2006 Jan 21; 26(1):28-40. PubMed ID: 16239592
    [Abstract] [Full Text] [Related]

  • 19. Present concepts and future outlook: function of peroxisome proliferator-activated receptors (PPARs) for pathogenesis, progression, and therapy of cancer.
    Sertznig P, Seifert M, Tilgen W, Reichrath J.
    J Cell Physiol; 2007 Jul 21; 212(1):1-12. PubMed ID: 17443682
    [Abstract] [Full Text] [Related]

  • 20. The toxicology of ligands for peroxisome proliferator-activated receptors (PPAR).
    Peraza MA, Burdick AD, Marin HE, Gonzalez FJ, Peters JM.
    Toxicol Sci; 2006 Apr 21; 90(2):269-95. PubMed ID: 16322072
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.